Cytosorbents Corporation (CTSO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.8700 |
| Open | 1.8500 |
| Bid | 0.0000 x 1000 |
| Ask | 0.0000 x 1000 |
| Day's range | 1.8300 - 1.9613 |
| 52-week range | 1.7750 - 9.8000 |
| Volume | |
| Avg. volume | 212,995 |
| Market cap | 82.332M |
| Beta (5Y monthly) | 0.48 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.6800 |
| Earnings date | 01 Aug 2022 - 05 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 8.83 |
- PR Newswire
CytoSorbents to Present at Two Upcoming Investor Conferences
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces management will present at two upcoming in–person investor conferences.
- Simply Wall St.
Cytosorbents Corporation (NASDAQ:CTSO): When Will It Breakeven?
With the business potentially at an important milestone, we thought we'd take a closer look at Cytosorbents...
- PR Newswire
CytoSorbents Reports First Quarter 2022 Results and Revises 2022 Outlook
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, today reported unaudited financial and operating results for the quarter ended March 31, 2022.
© 2022 Yahoo. All rights reserved.
